3 October 2022
Steps in the right direction!
FDA Modernization Act - The bill defines “nonclinical tests or studies ” as a test…
3 October 2022
An analysis of laboratory variability and thresholds for human in vitro ADME/PK methods
Fagerholm. BioRxiv September 28, 2022. https://www.biorxiv.org/content/10.1101/2022.09.27.509731v1
3 October 2022
New publications
An Analysis of Laboratory Variability and Thresholds for Human in vitro ADME/PK Methods & Prediction…
28 September 2022
Another publication
In vitro to in vivo pharmacokinetic translation guidance https://www.biorxiv.org/content/10.1101/2022.09.26.509470v1
28 September 2022
In vitro to in vivo pharmacokinetic translation guidance
Fagerholm. BioRxiv September 28, 2022. https://www.biorxiv.org/content/10.1101/2022.09.26.509470v1
27 September 2022
Investigation of Molecular Weights and Pharmacokinetic Characteristics of Older and Modern Small Drugs
Fagerholm. BioRxiv September 27, 2022. https://www.biorxiv.org/content/10.1101/2022.09.21.508888v1
27 September 2022
New publication
Investigation of Molecular Weights and Pharmacokinetic Characteristics of Older and Modern Small Drugs https://www.biorxiv.org/content/10.1101/2022.09.21.508888v1
24 September 2022
New publication
Prediction of Biopharmaceutical Characteristics of PROTACs using the ANDROMEDA by Prosilico Software https://www.biorxiv.org/content/10.1101/2022.09.22.509053v1
24 September 2022
Prediction of Biopharmaceutical Characteristics of PROTACs using the ANDROMEDA by Prosilico Software
Fagerholm, Hellberg, Alvarsson and Spjuth. BioRxiv September 24, 2022. https://www.biorxiv.org/content/10.1101/2022.09.22.509053v1
